Coherus BioSciences (CHRS)
(Delayed Data from NSDQ)
$1.39 USD
+0.07 (5.30%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $1.38 -0.01 (-0.72%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $-0.07 | -42.86% |
Earnings Summary
For their last quarter, Coherus BioSciences (CHRS) reported earnings of -$0.14 per share, beating the Zacks Consensus Estimate of $-0.21 per share. This reflects a positive earnings surprise of 33.33%. Look out for CHRS's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of -$0.07 per share, reflecting a year-over-year increase of 74.07%.
Earnings History
Price & Consensus
Zacks News for CHRS
Coherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates
CHRS: What are Zacks experts saying now?
Zacks Private Portfolio Services